Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Histone Modification-linked Prognostic Model For Ovarian Cancer Reveals Lbx2 As A Novel Growth Promoter

Histone modification-linked prognostic model for ovarian cancer reveals LBX2 as a novel growth promoter

Jian Xiong1, Hongyuan Liang2, Xiang Sun1

  • 1Department of Obstetrics and Gynecology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Journal of Cellular and Molecular Medicine
|March 23, 2024

Related Experiment Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.3K

View abstract on PubMed

Summary
This summary is machine-generated.

Histone modification genes can predict ovarian cancer (OC) prognosis. A new model identifies five key genes, offering potential for novel OC therapies and diagnostics.

Area of Science:

  • Oncology
  • Genetics
  • Epigenetics

Background:

  • Ovarian cancer (OC) presents significant challenges with limited treatment options and poor survival rates.
  • Histone modifications play a crucial role in cancer development and progression, yet their prognostic value in OC requires further elucidation.

Purpose of the Study:

  • To investigate the prognostic significance of histone modification-related genes in ovarian cancer.
  • To develop a predictive model for OC patient outcomes based on these genes.
  • To explore the relationship between histone modification genes, immune infiltration, and therapeutic targets in OC.

Main Methods:

  • Analysis of bulk and single-cell RNA sequencing data from multiple OC cohorts.
  • Gene set enrichment analysis to identify histone modification pathways.
Keywords:
LBX2immune infiltrationovarian cancerprognosis

Related Experiment Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.3K
  • Lasso regression for identifying differentially expressed genes (DEGs) and constructing a prognostic model.
  • In vitro experiments to validate gene expression patterns and functional roles.

    • Main Results:

    • Enrichment of histone modification pathways was observed in OC.
    • A five-gene prognostic model was developed, demonstrating correlation with immune cell infiltration (T cells, M1 macrophages) and mutation prevalence.
    • LBX2 was identified as a novel promoter of OC cell proliferation.
    • Drug screening against model genes identified potential therapeutic agents.

    Conclusions:

    • Histone modification-related genes serve as promising biomarkers for predicting OC prognosis.
    • Targeting these genes may offer new therapeutic strategies for ovarian cancer.
    • LBX2 warrants further investigation as a potential therapeutic target in OC progression.
    proliferation